Immune-inflammatory parameters in COVID-19 cases: a systematic review and meta-analysis

X Feng, S Li, Q Sun, J Zhu, B Chen, M Xiong… - Frontiers in …, 2020 - frontiersin.org
Background: The recent outbreak of coronavirus disease 2019 (COVID-19) has been rapidly
spreading on a global scale and poses a great threat to human health. Acute respiratory …

Interleukin 6, soluble interleukin 2 receptor alpha (CD25), monocyte colony-stimulating factor, and hepatocyte growth factor linked with systemic hyperinflammation …

L Quartuccio, M Fabris, A Sonaglia, M Peghin… - Cytokine, 2021 - Elsevier
Background Patients infected by SARS-CoV-2 can develop interstitial pneumonia, requiring
hospitalisation or mechanical ventilation. Increased levels of inflammatory biomarkers are …

Novel serological biomarkers for inflammation in predicting disease severity in patients with COVID-19

G Xue, X Gan, Z Wu, D Xie, Y Xiong, L Hua… - International …, 2020 - Elsevier
Background Patients with severe coronavirus disease 2019 (COVID-19) develop acute
respiratory distress and multi-system organ failure and are associated with poor prognosis …

[HTML][HTML] Mild versus severe COVID-19: Laboratory markers

TP Velavan, CG Meyer - International Journal of Infectious Diseases, 2020 - Elsevier
The number of COVID-19 patients is dramatically increasing worldwide. Treatment in
intensive care units (ICU) has become a major challenge; therefore, early recognition of …

Pro-and anti-inflammatory responses in severe COVID-19-induced acute respiratory distress syndrome—an observational pilot study

Q Notz, M Schmalzing, F Wedekink… - Frontiers in …, 2020 - frontiersin.org
Objectives The severity of Coronavirus Disease 2019 (COVID-19) is largely determined by
the immune response. First studies indicate altered lymphocyte counts and function …

Eosinopenia and elevated C-reactive protein facilitate triage of COVID-19 patients in fever clinic: a retrospective case-control study

Q Li, X Ding, G Xia, HG Chen, F Chen, Z Geng… - …, 2020 - thelancet.com
Abstract Background Coronavirus disease (COVID-19) caused by severe acute respiratory
syndrome coronavirus 2 (SARS-CoV-2) is currently a pandemic affecting over 200 countries …

Altered cytokine levels and immune responses in patients with SARS-CoV-2 infection and related conditions

R Noroozi, W Branicki, K Pyrc, PP Łabaj, E Pospiech… - Cytokine, 2020 - Elsevier
The severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) has caused a global
pandemic in early 2020. The infection has been associated with a wide range of clinical …

Non-respiratory presentations of COVID-19, a clinical review

M AlSamman, A Caggiula, S Ganguli, M Misak… - The American journal of …, 2020 - Elsevier
Introduction Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2 or COVID-19)
is a highly infectious viral syndrome currently threatening millions of people worldwide. It is …

Clinical laboratory evaluation of COVID-19

Z Chen, W Xu, W Ma, X Shi, S Li, M Hao, Y Fang… - Clinica Chimica …, 2021 - Elsevier
Abstract COVID-19, caused by SARS-CoV-2, is a highly infectious disease, and clinical
laboratory detection has played important roles in its diagnosis and in evaluating …

The immune system and COVID-19: Friend or foe?

F Yazdanpanah, MR Hamblin, N Rezaei - Life sciences, 2020 - Elsevier
Abstract Aim Coronavirus disease 2019 (COVID-19) is a novel highly contagious infection
caused by SARS-CoV-2, which has been became a global public health challenge. The …